Cargando…

The obesity paradox and hypoglycemia in critically ill patients

BACKGROUND: A high body mass index (BMI) has been associated with decreased mortality in critically ill patients. This association may, in part, relate to the impact of BMI on glycemia. We aimed to study the relationship between BMI, glycemia and hospital mortality. METHODS: We included all patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Plečko, Drago, Bennett, Nicolas, Mårtensson, Johan, Bellomo, Rinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559391/
https://www.ncbi.nlm.nih.gov/pubmed/34724956
http://dx.doi.org/10.1186/s13054-021-03795-z
_version_ 1784592750626209792
author Plečko, Drago
Bennett, Nicolas
Mårtensson, Johan
Bellomo, Rinaldo
author_facet Plečko, Drago
Bennett, Nicolas
Mårtensson, Johan
Bellomo, Rinaldo
author_sort Plečko, Drago
collection PubMed
description BACKGROUND: A high body mass index (BMI) has been associated with decreased mortality in critically ill patients. This association may, in part, relate to the impact of BMI on glycemia. We aimed to study the relationship between BMI, glycemia and hospital mortality. METHODS: We included all patients with a recorded BMI from four large international clinical databases (n = 259,177). We investigated the unadjusted association of BMI with average glucose levels, mortality and hypoglycemia rate. We applied multivariate analysis to investigate the impact of BMI on hypoglycemia rate, after adjusting for glycemia-relevant treatments (insulin, dextrose, corticosteroids, enteral and parenteral nutrition) and key physiological parameters (previous blood glucose level, blood lactate, shock state, SOFA score). RESULTS: We analyzed 5,544,366 glucose measurements. On unadjusted analysis, increasing BMI was associated with increasing glucose levels (average increase of 5 and 10 mg/dL for the 25–30, 30–35 kg/m(2) BMI groups compared to normal BMI (18.5–25 kg/m(2)) patients). Despite greater hyperglycemia, increasing BMI was associated with lower hospital mortality (average decrease of 2% and 3.25% for the 25–30, 30–35 kg/m(2) groups compared to normal BMI patients) and lower hypoglycemia rate (average decrease of 2.5% and 3.5% for the 25–30, 30–35 kg/m(2) groups compared to normal BMI patients). Increasing BMI was significantly independently associated with reduced hypoglycemia rate, with odds ratio (OR) 0.72 and 0.65, respectively (95% CIs 0.67–0.77 and 0.60–0.71, both p < 0.001) when compared with normal BMI. Low BMI patients showed greater hypoglycemia rate, with OR 1.6 (CI 1.43–1.79, p < 0.001). The association of high BMI and decreased mortality did not apply to diabetic patients. Although diabetic patients had higher rates of hypoglycemia overall and higher glucose variability (p < 0.001), they also had a reduced risk of hypoglycemia with higher BMI levels (p < 0.001). CONCLUSIONS: Increasing BMI is independently associated with decreased risk of hypoglycemia. It is also associated with increasing hyperglycemia and yet with lower mortality. Lower risk of hypoglycemia might contribute to decreased mortality and might partly explain the obesity paradox. These associations, however, were markedly modified by the presence of diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03795-z.
format Online
Article
Text
id pubmed-8559391
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85593912021-11-03 The obesity paradox and hypoglycemia in critically ill patients Plečko, Drago Bennett, Nicolas Mårtensson, Johan Bellomo, Rinaldo Crit Care Research BACKGROUND: A high body mass index (BMI) has been associated with decreased mortality in critically ill patients. This association may, in part, relate to the impact of BMI on glycemia. We aimed to study the relationship between BMI, glycemia and hospital mortality. METHODS: We included all patients with a recorded BMI from four large international clinical databases (n = 259,177). We investigated the unadjusted association of BMI with average glucose levels, mortality and hypoglycemia rate. We applied multivariate analysis to investigate the impact of BMI on hypoglycemia rate, after adjusting for glycemia-relevant treatments (insulin, dextrose, corticosteroids, enteral and parenteral nutrition) and key physiological parameters (previous blood glucose level, blood lactate, shock state, SOFA score). RESULTS: We analyzed 5,544,366 glucose measurements. On unadjusted analysis, increasing BMI was associated with increasing glucose levels (average increase of 5 and 10 mg/dL for the 25–30, 30–35 kg/m(2) BMI groups compared to normal BMI (18.5–25 kg/m(2)) patients). Despite greater hyperglycemia, increasing BMI was associated with lower hospital mortality (average decrease of 2% and 3.25% for the 25–30, 30–35 kg/m(2) groups compared to normal BMI patients) and lower hypoglycemia rate (average decrease of 2.5% and 3.5% for the 25–30, 30–35 kg/m(2) groups compared to normal BMI patients). Increasing BMI was significantly independently associated with reduced hypoglycemia rate, with odds ratio (OR) 0.72 and 0.65, respectively (95% CIs 0.67–0.77 and 0.60–0.71, both p < 0.001) when compared with normal BMI. Low BMI patients showed greater hypoglycemia rate, with OR 1.6 (CI 1.43–1.79, p < 0.001). The association of high BMI and decreased mortality did not apply to diabetic patients. Although diabetic patients had higher rates of hypoglycemia overall and higher glucose variability (p < 0.001), they also had a reduced risk of hypoglycemia with higher BMI levels (p < 0.001). CONCLUSIONS: Increasing BMI is independently associated with decreased risk of hypoglycemia. It is also associated with increasing hyperglycemia and yet with lower mortality. Lower risk of hypoglycemia might contribute to decreased mortality and might partly explain the obesity paradox. These associations, however, were markedly modified by the presence of diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03795-z. BioMed Central 2021-11-01 /pmc/articles/PMC8559391/ /pubmed/34724956 http://dx.doi.org/10.1186/s13054-021-03795-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Plečko, Drago
Bennett, Nicolas
Mårtensson, Johan
Bellomo, Rinaldo
The obesity paradox and hypoglycemia in critically ill patients
title The obesity paradox and hypoglycemia in critically ill patients
title_full The obesity paradox and hypoglycemia in critically ill patients
title_fullStr The obesity paradox and hypoglycemia in critically ill patients
title_full_unstemmed The obesity paradox and hypoglycemia in critically ill patients
title_short The obesity paradox and hypoglycemia in critically ill patients
title_sort obesity paradox and hypoglycemia in critically ill patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559391/
https://www.ncbi.nlm.nih.gov/pubmed/34724956
http://dx.doi.org/10.1186/s13054-021-03795-z
work_keys_str_mv AT pleckodrago theobesityparadoxandhypoglycemiaincriticallyillpatients
AT bennettnicolas theobesityparadoxandhypoglycemiaincriticallyillpatients
AT martenssonjohan theobesityparadoxandhypoglycemiaincriticallyillpatients
AT bellomorinaldo theobesityparadoxandhypoglycemiaincriticallyillpatients
AT pleckodrago obesityparadoxandhypoglycemiaincriticallyillpatients
AT bennettnicolas obesityparadoxandhypoglycemiaincriticallyillpatients
AT martenssonjohan obesityparadoxandhypoglycemiaincriticallyillpatients
AT bellomorinaldo obesityparadoxandhypoglycemiaincriticallyillpatients